# Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension

> **NCT00947661** · PHASE3 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 578 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** SPARC0912
- **DRUG:** Reference0912

## Key facts

- **NCT ID:** NCT00947661
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 578 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947661, "Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00947661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*